ABIRATERONE ACETATE | A212462 | QILU PHARMACEUTICAL CO LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
BTG INTERNATIONAL LIMITED et al v. QILU PHARMACEUTICAL CO., LTD. et al 1 patentANDA 212462abiraterone acetate | D.N.J. | 2018-11-28 | Terminated 2019-05-28 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$3.02
per ea
Lowest NADAC/Unit
$0.8305
per ea
Brand NDCs
0
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 60505476406ABIRATERONE ACETATE 500 MG TAB | $3.02 | EA | Generic | — | 2026-06-17 |
| 71921017820ABIRATERONE ACETATE 250 MG TAB | $0.8305 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.